A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia.
Jung
K
K
Department of Urology, University Hospital Charité, Humboldt University Berlin, Germany. klaus.jung@charite.de
Brux
B
B
Knäbich
A
A
Lein
M
M
Sinha
P
P
Schnorr
D
D
Loening
S A
SA
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood* / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood*; D000514:alpha 1-Antichymotrypsin / Q000097:blood* / Q000378:metabolism
D000514:alpha 1-Antichymotrypsin; D017430:Prostate-Specific Antigen